Portfolio Sync Solutions
Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced
GET STARTEDJourney Medical Corp Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2026 | 3 | -$0.11 | -$0.06 | -$0.09 |
| Q2 2026 | 3 | -$0.08 | $0.04 | -$0.02 |
| Q3 2026 | 1 | $0.05 | $0.06 | $0.06 |
| Q4 2026 | 1 | $0.11 | $0.12 | $0.12 |
| Q1 2027 | 1 | $0.02 | $0.02 | $0.02 |
| Q2 2027 | 1 | $0.08 | $0.08 | $0.08 |
| Q3 2027 | 1 | $0.17 | $0.17 | $0.17 |
| Q4 2027 | 1 | $0.18 | $0.19 | $0.18 |
Journey Medical Corp Earnings Date And Information
Journey Medical Corp last posted its earnings results on Wednesday, March 25th, 2026. The company reported $-0.04 earnings per share for the quarter, topping analysts' consensus estimates of $-0.06 by $0.02. The company had revenue of 15.96 M for the quarter and had revenue of 61.86 M for the year. Journey Medical Corp has generated $0 earnings per share over the last year ($-0.47 diluted earnings per share) and currently has a price-to-earnings ratio of -14.78. Journey Medical Corp has not formally confirmed its next earnings publication date, but the company's estimated earnings date is N/A based on prior year's report dates.
Journey Medical Corp Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 05/13/2026 | Q1 2026 | N/A | -$0.08 | N/A | $15.47 M | $15.96 M |
| 03/25/2026 | Q4 2025 | N/A | -$0.05 | N/A | $18.85 M | $16.08 M |
| 11/12/2025 | Q3 2025 | -$0.08 | -$0.09 | -0.01 | $18.86 M | $17.63 M |
| 08/12/2025 | Q2 2025 | -$0.07 | -$0.16 | -0.09 | $14.79 M | $15.01 M |
| 05/15/2025 | Q1 2025 | N/A | -$0.18 | N/A | $12.08 M | $13.14 M |
| 03/26/2025 | Q4 2024 | N/A | $0.07 | N/A | $14.01 M | $13.62 M |
| 11/12/2024 | Q3 2024 | -$0.17 | -$0.12 | 0.05 | $14.39 M | $14.63 M |
| 08/12/2024 | Q2 2024 | N/A | -$0.17 | N/A | $13.89 M | $14.86 M |
| 05/14/2024 | Q1 2024 | N/A | -$0.53 | N/A | $14.11 M | $13.03 M |
| 03/28/2024 | Q4 2023 | N/A | -$0.11 | N/A | N/A | $15.26 M |
| 11/09/2023 | Q3 2023 | N/A | $0.91 | N/A | N/A | $34.54 M |
| 08/10/2023 | Q2 2023 | N/A | -$0.46 | N/A | N/A | $17.17 M |
| 05/22/2023 | Q1 2023 | -$0.44 | -$0.56 | -0.12 | N/A | $12.21 M |
| 03/30/2023 | Q4 2022 | N/A | -$0.60 | N/A | N/A | $15.97 M |
| 11/10/2022 | Q3 2022 | -$0.34 | -$0.57 | -0.23 | N/A | $16.12 M |
| 08/09/2022 | Q2 2022 | -$0.25 | -$0.43 | -0.18 | N/A | $18.29 M |
| 05/10/2022 | Q1 2022 | -$0.18 | -$0.08 | 0.1 | N/A | $23.30 M |
| 03/28/2022 | Q4 2021 | N/A | -$1.64 | N/A | N/A | $17.52 M |
| 12/15/2021 | Q3 2021 | N/A | -$1.16 | N/A | N/A | $19.61 M |
| 06/29/2021 | Q2 2021 | N/A | -$1.30 | N/A | N/A | $15.29 M |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Journey Medical Corp Earnings: FAQ's
In the previous quarter, Journey Medical Corp (:DERM) reported $-0.04 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.06 by $0.02.
The conference call for Journey Medical Corp's latest earnings report can be listened to online.
The conference call transcript for Journey Medical Corp's latest earnings report can be read online.
Journey Medical Corp (:DERM) has a recorded annual revenue of $61.86 M.
Journey Medical Corp (:DERM) has a recorded net income of $-11,431,000.Journey Medical Corp has generated $-0.47 earnings per share over the last four quarters.
Journey Medical Corp (:DERM) has a price-to-earnings ratio of -14.78 and price/earnings-to-growth ratio is 1.33.